Eric Farber‐Eger

2.7k total citations
72 papers, 1.2k citations indexed

About

Eric Farber‐Eger is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Eric Farber‐Eger has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 19 papers in Pulmonary and Respiratory Medicine and 15 papers in Genetics. Recurrent topics in Eric Farber‐Eger's work include Cardiovascular Function and Risk Factors (17 papers), Pulmonary Hypertension Research and Treatments (16 papers) and Genetic Associations and Epidemiology (13 papers). Eric Farber‐Eger is often cited by papers focused on Cardiovascular Function and Risk Factors (17 papers), Pulmonary Hypertension Research and Treatments (16 papers) and Genetic Associations and Epidemiology (13 papers). Eric Farber‐Eger collaborates with scholars based in United States, Germany and Canada. Eric Farber‐Eger's co-authors include Quinn S. Wells, Evan L. Brittain, Anna R. Hemnes, Meng Xu, Tufik R. Assad, Frank E. Harrell, Dana C. Crawford, Thomas J. Wang, Deepak K. Gupta and Shi Huang and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Eric Farber‐Eger

70 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Farber‐Eger United States 17 730 571 133 131 131 72 1.2k
W. Craig Johnson United States 16 655 0.9× 723 1.3× 150 1.1× 174 1.3× 146 1.1× 25 1.5k
A. Argyropoulos United Kingdom 11 599 0.8× 438 0.8× 126 0.9× 204 1.6× 111 0.8× 24 2.0k
Erwan Bozec France 21 1.3k 1.8× 512 0.9× 111 0.8× 324 2.5× 109 0.8× 79 1.9k
Xuejuan Jin China 18 359 0.5× 321 0.6× 128 1.0× 294 2.2× 202 1.5× 64 1.2k
Lidia Mosconi Italy 19 450 0.6× 527 0.9× 182 1.4× 266 2.0× 76 0.6× 24 2.0k
Rajan K. Patel United Kingdom 20 448 0.6× 195 0.3× 92 0.7× 185 1.4× 72 0.5× 44 1.1k
Joe Coresh United States 14 334 0.5× 142 0.2× 89 0.7× 160 1.2× 247 1.9× 21 1.2k
Hesong Zeng China 20 696 1.0× 243 0.4× 201 1.5× 303 2.3× 107 0.8× 81 1.5k
Zhenguo Zhai China 22 941 1.3× 857 1.5× 235 1.8× 244 1.9× 354 2.7× 188 2.3k
Antonio Iglesias del Sol Netherlands 11 1.1k 1.5× 702 1.2× 56 0.4× 327 2.5× 290 2.2× 19 1.7k

Countries citing papers authored by Eric Farber‐Eger

Since Specialization
Citations

This map shows the geographic impact of Eric Farber‐Eger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Farber‐Eger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Farber‐Eger more than expected).

Fields of papers citing papers by Eric Farber‐Eger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Farber‐Eger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Farber‐Eger. The network helps show where Eric Farber‐Eger may publish in the future.

Co-authorship network of co-authors of Eric Farber‐Eger

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Farber‐Eger. A scholar is included among the top collaborators of Eric Farber‐Eger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Farber‐Eger. Eric Farber‐Eger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shuey, Megan M., Rebecca T. Levinson, Eric Farber‐Eger, et al.. (2025). Risk of Coronary Artery Disease Associated With Transitions in Metabolic Health in a Clinical Cohort of 69 272. Journal of the American Heart Association. 14(23). e037597–e037597.
2.
Cho, So Mi Jemma, Michael G. Levin, Renae Judy, et al.. (2025). AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care Populations. Journal of the American College of Cardiology. 86(3). 181–192. 7 indexed citations
3.
Wood, Kathryn, et al.. (2025). Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases. The Journal of Clinical Endocrinology & Metabolism. 111(1). e49–e57. 1 indexed citations
4.
Wood, Kathryn, et al.. (2024). Cardiometabolic characteristics of weight cycling: results from a mid‐South regional comprehensive health care system. Obesity. 32(11). 2045–2059. 2 indexed citations
5.
Liu, Chang, Qin Hui, Quinn S. Wells, et al.. (2024). A Multivariable Mendelian Randomization Study of Systolic and Diastolic Blood Pressure, Lipid Profile, and Heart Failure Subtypes. Genes. 15(9). 1126–1126. 1 indexed citations
6.
Akwo, Elvis A., Mindy Pike, Lale A. Ertuğlu, et al.. (2022). Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure. Clinical Journal of the American Society of Nephrology. 17(8). 1183–1193. 10 indexed citations
7.
Hemnes, Anna R., et al.. (2022). An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record. Respiratory Research. 23(1). 138–138. 9 indexed citations
8.
Delozier, Sarah, Harris T. Bland, Melissa L McPheeters, et al.. (2021). Phenotyping coronavirus disease 2019 during a global health pandemic: Lessons learned from the characterization of an early cohort. Journal of Biomedical Informatics. 117. 103777–103777. 7 indexed citations
9.
Farber‐Eger, Eric, et al.. (2020). Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record. The American Journal of Medicine. 134(2). e98–e100. 3 indexed citations
10.
Bottinor, Wendy, Ali Manouchehri, Eric Farber‐Eger, et al.. (2019). Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition. JACC CardioOncology. 1(1). 14–23. 19 indexed citations
11.
Meng, Xu, Eric Farber‐Eger, Marcia Blair, et al.. (2019). INITIAL CHANGES IN PEAK AORTIC JET VELOCITY AND MEAN GRADIENT PREDICT PROGRESSION TO SEVERE AORTIC STENOSIS. Journal of the American College of Cardiology. 73(9). 1966–1966. 3 indexed citations
12.
Yang, Bin, Tufik R. Assad, Jared O’Leary, et al.. (2018). Racial differences in patients referred for right heart catheterization and risk of pulmonary hypertension. Pulmonary Circulation. 8(2). 1–9. 14 indexed citations
13.
Gupta, Deepak K., Eric Farber‐Eger, Quinn S. Wells, et al.. (2018). B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure. Journal of the American College of Cardiology. 71(19). 2079–2088. 92 indexed citations
14.
Wunderer, Florian, Daniel S. Perrien, Eric Farber‐Eger, et al.. (2017). Abstract 16421: Inhibition of Bone Morphogenetic Protein (BMP) Signaling Mitigates Nonalcoholic Fatty Liver Disease (NAFLD) and Identification of an Activating BMP Receptor Polymorphism Associated With NAFLD. Circulation. 1 indexed citations
15.
Huston, Jessica, Tufik R. Assad, J. French, et al.. (2017). Abstract 15765: Echocardiographic Pulmonary Arterial Pressure Estimates and Mortality: Evidence of Increased Risk at "Normal" Values. Circulation. 1 indexed citations
16.
Yang, Bin, Tufik R. Assad, Stephen Halliday, et al.. (2017). RACIAL DIFFERENCES IN PATIENTS REFERRED FOR RIGHT HEART CATHETERIZATION AND RISK OF PULMONARY HYPERTENSION. Journal of the American College of Cardiology. 69(11). 1877–1877. 1 indexed citations
17.
Chen, Xinping, Eric D. Austin, Megha Talati, et al.. (2017). Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. European Respiratory Journal. 50(2). 1602337–1602337. 60 indexed citations
18.
Assad, Tufik R., Evan L. Brittain, Quinn S. Wells, et al.. (2016). Hemodynamic Evidence of Vascular Remodeling in Combined Post‐ and Precapillary Pulmonary Hypertension. Pulmonary Circulation. 6(3). 313–321. 35 indexed citations
19.
Assad, Tufik R., Anna R. Hemnes, Emma K. Larkin, et al.. (2016). Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension. Journal of the American College of Cardiology. 68(23). 2525–2536. 142 indexed citations
20.
Farber‐Eger, Eric, et al.. (2015). Improving access to socioeconomic data for genetic studies of racial health disparities. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Craig Johnson Breakdown of academic impact, for papers by A. Argyropoulos Breakdown of academic impact, for papers by Erwan Bozec Breakdown of academic impact, for papers by Xuejuan Jin Breakdown of academic impact, for papers by Lidia Mosconi Breakdown of academic impact, for papers by Rajan K. Patel Breakdown of academic impact, for papers by Joe Coresh Breakdown of academic impact, for papers by Hesong Zeng Breakdown of academic impact, for papers by Zhenguo Zhai Breakdown of academic impact, for papers by Antonio Iglesias del Sol
Rankless by CCL
2026